Cargando…
Clinical risk stratification of paediatric renal transplant recipients using C1q and C3d fixing of de novo donor-specific antibodies
INTRODUCTION: We have previously shown that children who developed de novo donor-specific human leukocyte antigen (HLA) antibodies (DSA) had greater decline in allograft function. We hypothesised that patients with complement-activating DSA would have poorer renal allograft outcomes. METHODS: A tota...
Autores principales: | Kim, Jon Jin, Shaw, Olivia, Martin, Chloe, Michaelides, George, Balasubramaniam, Ramnath, Sebire, Neil J., Mamode, Nizam, Dorling, Anthony, Vaughan, Robert, Marks, Stephen D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700253/ https://www.ncbi.nlm.nih.gov/pubmed/28918487 http://dx.doi.org/10.1007/s00467-017-3772-7 |
Ejemplares similares
-
Desensitization protocol enabling pediatric crossmatch-positive renal transplantation: successful HLA-antibody-incompatible renal transplantation of two highly sensitized children
por: Adamusiak, Anna M., et al.
Publicado: (2016) -
Utilisation of small paediatric donor kidneys for transplantation
por: Damji, Samir, et al.
Publicado: (2018) -
Can pre-implantation biopsies predict renal allograft function in pediatric renal transplant recipients?
por: Kari, Jameela A., et al.
Publicado: (2015) -
Safety and efficacy of eculizumab in the prevention of antibody‐mediated rejection in living‐donor kidney transplant recipients requiring desensitization therapy: A randomized trial
por: Marks, William H., et al.
Publicado: (2019) -
Solid-Phase C1q/C3d Fixing Readouts Correlate with High Median Fluorescence Intensity (MFI) De Novo Donor-Specific HLA Antibodies and C4d(+) Antibody-Mediated Rejection in Kidney Transplant Recipients
por: Tatapudi, Vasishta S., et al.
Publicado: (2021)